STAT3 is constitutively hyperactivated in DFT1, involved in the down-regulation of MHC-I in this tumour [81], and here we have demonstrated that DFT2 cells express similar levels of STAT3 to DFT1, despite still expressing MHC-I (Fig 3D). The gene discussed is STAT3; the disease is neoplasm.